| | | |  | |
 | | | Not Everyone Is Feeling Yesterday's Pain | | Matthew Carr | Chief Trends Strategist | The Oxford Club | | | | | The broader markets were in meltdown mode yesterday.
The latest strain of China syndrome had investors feeling sick to their stomachs as trade talks crumbled.
That's unfortunately bleeding into everything else. Even sectors like cannabis that aren't exposed to the trade war.
But while the major indexes are going to rise and fall with the most heavily weighted stocks, there are still gains being made... if you know where to look.
Blood in the Streets
Yesterday, the Dow Jones Industrial Average lost more than 3%. Small caps on the Russell 2000 did even worse, tumbling nearly 3.5%. But the tech stocks on the Nasdaq were the hardest hit, plummeting almost 4%. | | | The broad collapse marked the fifth straight day of declines and earned an even more dour distinction: the worst day for stocks in 2019.
A lot of that pain came from the market's "fab five."
The beloved FAANG stocks - Facebook (Nasdaq: FB), Apple (Nasdaq: AAPL), Amazon (Nasdaq: AMZN), Netflix (Nasdaq: NFLX) and Google parent company Alphabet (Nasdaq: GOOGL) - have struggled over the past month... These are the five most heavily weighted stocks in the Nasdaq and S&P 500. And where these five go, the rest of the market typically follows.
Now, investors love acronyms. And I wish I could come up with a better one for cannabis's version of the FAANGs... But my Scrabble skills have yet to unearth something usable.
Over the past month, four of the most heavily weighted cannabis stocks have performed much like the word their initials spell... Shares of Canopy Growth Corp. (NYSE: CGC), Aurora Cannabis (NYSE: ACB), Cronos Group (Nasdaq: CRON) and Aphria (NYSE: APHA) have been in the toilet the past few weeks.
These four have lost 12% or more in the last month. And only Aphria's more than 35% gain on Friday put its 30-day performance in the green.
The Cannabis Outliers
There have been a lot of headline headwinds lately with CEO oustings, scandals and what's perceived as legislative stalls.
And the cannabis sector and indexes have largely struggled because of that.
But that doesn't mean there haven't been outperformers.
Here are some of the pot stocks that have posted the best returns over the past month... First things first... the majority of these are American pot stocks.
Some of them might be headquartered in Canada. But their operations are in the U.S.
For instance, DionyMed Brands (OTC: DYMEF) has surged on a number of deals, particularly with Innovative Industrial Properties (NYSE: IIPR), as it expands into the California edibles market.
Meanwhile, Auxly Cannabis Group (OTC: CBWTF) is flying because of its $123 million investment from Imperial Brands (OTC: IMBBY).
And Charlotte's Web Holdings (OTC: CWBHF) can't be stopped as it signed its largest distribution deal yet, and shares have taken off, nearing 52-week highs.
But we've also seen strong momentum from the Sunshine State's Veritas Farms (OTC: VFRM), as it too announced a partnership with Kroger (NYSE: KR). California gummy producer Plus Products (OTC: PLPRF), fellow Floridian Exactus (OTC: EXDI), and Canadian and U.S. extractor Neptune Wellness Solutions (Nasdaq: NEPT) have also notched solid performances over the past month.
Not to mention, Curaleaf Holdings (OTC: CURLF) is riding high as it's now the largest multistate operator in the U.S. following its $875 million acquisition of GR Companies.
The broader markets are feeling the pinch from the tariff tantrum once again. And that's unfortunately going to spoil everything.
Those major indexes will rise and fall with the FAANGs. And pot stocks will do the same with their own "fab five," even if investors don't have an acronym to latch onto.
But outside those heavyweights, there are still gains being made... especially in American pot stocks.
Here's to high returns,
Matthew
P.S. This fall, I'll be presenting at the legendary New Orleans Investment Conference.
Simply put, this is one of the most important investment gatherings of the year. It brings together the brightest, most successful analysts and investors.
I'll be joined by Doug Casey, Rick Rule, Mark Skousen and dozens more industry-leading experts.
We'll cover gold, cannabis, fintech, 5G, real estate, economics - you name it!
So if you want the inside track on a few powerful, irreversible trends that will create fortunes in the months ahead...
And if you want an excuse to visit the Big Easy...
It's a no-brainer.
As one of my valued readers - when you use THIS LINK to sign up today - you'll receive a $400 discount on your registration... as well as a Gold Club upgrade.
Don't miss out! | | | | |  | | | | | |  |  | | | | Matthew Carr | August 5, 2019 Both Canadian and American pot stocks made big moves higher last week. This was the start of the turnaround we've been waiting for. Read More | | | | |  | | | | Anthony Summers | August 3, 2019 Benjamin Graham taught us that sometimes very simple methods yield exceptional results. Read More | | | | |  | | | | Matthew Carr | August 1, 2019 The rise in CBD products has created an even bigger opportunity in one industry: extraction. Read More | | | | | | | | | | |
|
The Oxford Club is a financial publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or investment for any specific individual. Members should be aware that although our track record is highly rated by an independent analysis and has been legally reviewed, investment markets have inherent risks and there can be no guarantee of future profits. The stated returns may also include option trades. 
No comments:
Post a Comment